CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- S-3 Offering Registration Statement
- 8-K Event Agreement ended
- 4 Grant or award Director acquired 11,627,907 shares (grant or award)
- SC 13D/A Stake Beneficial Ownership Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- SC 13G Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President and CEO acquired 172,500 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 76,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 86,000 shares (grant or award)
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
Page 19 of 24 · 464 filings